| Accreditation in India: pathways and mechanisms S Das, M Shah, A Mane, V Goyal, V Singh, J Lele Journal of European CME 7 (1), 1454251, 2018 | 14 | 2018 |
| Review On: " The Aspects of Punica Granatum " SS Manan Shah Journal of Pharmaceutical Science and Bioscientific Research 1 (3), 154-159, 2011 | 12 | 2011 |
| Cardiovascular event costs in patients with type 2 diabetes mellitus SS Johnston, JJ Sheehan, M Shah, K Cappell, N Princic, D Smith, ... Journal of medical economics 18 (12), 1032-1040, 2015 | 11 | 2015 |
| Long-term clinical benefits of canagliflozin 100 mg versus sulfonylurea in patients with type 2 diabetes mellitus inadequately controlled with metformin in India V Gupta, M Willis, P Johansen, A Nilsson, M Shah, A Mane, C Neslusan Value in Health Regional Issues 18, 65-73, 2019 | 5 | 2019 |
| Introductory chapter: Pharmacovigilance CS Kothari, MP Shah, RM Patel Pharmacovigilance, 2018 | 1 | 2018 |
| In-depth review on ‘innovation and regulatory challenges of the drug delivering medical devices’ SS Manan Shah, Charmy Kothari, Drashti Patel Journal of Generic Medicines 15 (1), 18-28, 2018 | 1* | 2018 |
| Cost of major adverse cardiac events (MACE) among type 2 diabetes mellitus (T2DM) patients with obesity, renal impairment, or varying cardiovascular risk S Johnston, M Shah, J Sheehan, K Cappell, N Princic, DM Smith, ... Diabetes 63, A619-A619, 2014 | 1 | 2014 |
| PMH3 Desogestrel: Does IT Cause Severe Psychiatric Disorders, a Retrospective Analysis of FDA Adverse Event Reporting System and Eudravigilance M Shah, C Kothari Value in Health Regional Issues 22, S62, 2020 | | 2020 |
| PDG29 DROSPIRENONE INDUCED GALL BLADDER DISEASES: A RETROSPECTIVE STUDY OF EUDRAVIGILANCE DATABASE M Shah Value in Health 23, S134, 2020 | | 2020 |
| Raw Data Management and Data Integrity in Pharmaceutical Product development J Parmar, P Mehta, R Patel, M Shah, C Kothari Applied Clinical Research, Clinical Trials and Regulatory Affairs, 2020 | | 2020 |
| Desogestrel and severe psychiatric disorders, a retrospective analysis of Federal Adverse Event Reporting System and Eudravigilance Current Drug Safety M Shah, C Kothari Current Drug Safety, 2020 | | 2020 |
| Comparative Safety Assessment study for Drospirenone Induced Gallbladder Diseases using the Adverse Drug Reaction Database of USA, Europe, and Canada M Shah, C Kothari Current Drug Safety, 2020 | | 2020 |
| Drospirenone and Its Association with Gall Bladder Diseases: A Retrospective Study of Canadian Adverse Drug Reaction Monitoring Program, 1965-2017 M Shah, C Kothari DRUG SAFETY 41 (11), 1145-1145, 2018 | | 2018 |
| Drospirenone and Its Association with Gall Bladder Diseases: A Retrospective Study of Canadian Adverse Drug Reaction Monitoring Program, 1965–2017 CK M. Shah 18th ISoP Annual Meeting ‘‘Pharmacovigilance without borders’’ Geneva …, 2018 | | 2018 |
| Introductory Chapter: Pharmacovigilance CK Manan Shah Pharmacovigilance 1, 1-15, 2018 | | 2018 |
| REGULATORY TECHNICALITIES FOR DRUG PRODUCT REGISTRATION IN BRAZIL SM Vaishnav Mohak, Kothari Charmy International Journal of Drug Regulatory Affairs 5 (4), 18-25, 2017 | | 2017 |
| Role of PDA in shared decision making in treatment of T2DM: A novel concept for diabetes management in India. V Deshmukh, R Bailey, MV Fegade, G Singh, M Shah, A Mane Indian Journal of Endocrinology & Metabolism 21, 2017 | | 2017 |
| ESICON 2016 Abstracts V Deshmukh, R Bailey, M Vinayak, G Singh, M Shah, A Mane Indian Journal of Endocrinology and Metabolism 21 (Suppl 1), S1-S90, 2017 | | 2017 |
Charmy KothariAssociate Professor, Institute of Pharmacy, Nirma UniversityVerified email at nirmauni.ac.in
